Structural analysis between arsenic and CYP2C8 enzyme interaction by docking

被引：0
|
作者：
Rangel Lopez, A. [1 ,2 ]
Nieto Delgado, G. [2 ]
Vertiz Hernandez, A. [1 ,2 ]
Terrones Gurrola, R. [1 ,2 ]
机构：
[1] Univ Autonoma San Luis Potosi, Matehuala, Mexico
[2] Univ Autonoma San Luis Potosi, San Luis Potosi, Mexico
来源：
JOURNAL OF NEUROCHEMISTRY | 2013年 / 125卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：164 / 164
页数：1
相关论文
共 50 条
  • [1] Genetic polymorphism of CYP2C8 in three Malaysian ethnics:: CYP2C8*2 and CYP2C8*3 are found in Malaysian Indians
    Muthiah, YD
    Lee, WL
    Teh, LK
    Ong, CE
    Ismail, R
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2005, 30 (05) : 487 - 490
  • [2] Stereoselective interaction between the CYP2C8 inhibitor gemfibrozil and racemic ibuprofen
    Aleksi Tornio
    Mikko Niemi
    Pertti J. Neuvonen
    Janne T. Backman
    European Journal of Clinical Pharmacology, 2007, 63 : 463 - 469
  • [3] Stereoselective interaction between the CYP2C8 inhibitor gemfibrozil and racemic ibuprofen
    Tornio, Aleksi
    Niemi, Mikko
    Neuvonen, Pertti J.
    Backman, Janne T.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 63 (05) : 463 - 469
  • [4] Amiodarone N-deethylation by CYP2C8 and its variants, CYP2C8*3 and CYP2C8 P404A
    Soyama, A
    Hanioka, N
    Saito, Y
    Murayama, N
    Ando, M
    Ozawa, S
    Sawada, J
    PHARMACOLOGY & TOXICOLOGY, 2002, 91 (04): : 174 - 178
  • [5] Brivaracetam CYP2C8 interaction study in healthy subjects
    Hulhoven, R.
    Scheen, A.
    Watanabe, S.
    Valgaeren, A.
    Trocnaru, M. M.
    Sargentini-Maier, M. L.
    Stockis, A.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 48 (09): : 1111 - 1111
  • [6] Interplay of UDP-Glucuronosyltransferase and CYP2C8 for CYP2C8 Mediated Drug Oxidation and Its Impact on Drug–Drug Interaction Produced by Standardized CYP2C8 Inhibitors, Clopidogrel and Gemfibrozil
    Katsumi Iga
    Akiko Kiriyama
    Clinical Pharmacokinetics, 2024, 63 : 43 - 56
  • [7] Linkage between the CYP2C8 and CYP2C9 genetic polymorphisms
    Yasar, U
    Lundgren, S
    Eliasson, E
    Bennet, A
    Wiman, B
    de Faire, U
    Rane, A
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 299 (01) : 25 - 28
  • [8] Interplay of UDP-Glucuronosyltransferase and CYP2C8 for CYP2C8 Mediated Drug Oxidation and Its Impact on Drug-Drug Interaction Produced by Standardized CYP2C8 Inhibitors, Clopidogrel and Gemfibrozil
    Iga, Katsumi
    Kiriyama, Akiko
    CLINICAL PHARMACOKINETICS, 2024, 63 (01) : 43 - 56
  • [9] Influence of CYP2C8☆13 and CYP2C8☆14 Alleles on Amiodarone N-Deethylation
    Hanioka, Nobumitsu
    Matsumoto, Kimiaki
    Saito, Yoshiro
    Narimatsu, Shizuo
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2011, 108 (05) : 359 - 362
  • [10] Evaluation of CYP2C8 Inhibition In Vitro: Utility of Montelukast as a Selective CYP2C8 Probe Substrate
    VandenBrink, Brooke M.
    Foti, Robert S.
    Rock, Dan A.
    Wienkers, Larry C.
    Wahlstrom, Jan L.
    DRUG METABOLISM AND DISPOSITION, 2011, 39 (09) : 1546 - 1554
12345